• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性乳腺癌中的表观遗传学:生物学特征与治疗展望。

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.

机构信息

Department of Gynecology and Obstetrics, Medical School, São Paulo State University (UNESP), Botucatu 18618-687, São Paulo, Brazil.

Hermínio Ometto Foundation, Araras 13607-339, São Paulo, Brazil.

出版信息

Cells. 2020 May 8;9(5):1164. doi: 10.3390/cells9051164.

DOI:10.3390/cells9051164
PMID:32397183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7291154/
Abstract

Evidence has emerged implicating epigenetic alterations in inflammatory breast cancer (IBC) origin and progression. IBC is a rare and rapidly progressing disease, considered the most aggressive type of breast cancer (BC). At clinical presentation, IBC is characterized by diffuse erythema, skin ridging, dermal lymphatic invasion, and peau d'orange aspect. The widespread distribution of the tumor as emboli throughout the breast and intra- and intertumor heterogeneity is associated with its poor prognosis. In this review, we highlighted studies documenting the essential roles of epigenetic mechanisms in remodeling chromatin and modulating gene expression during mammary gland differentiation and the development of IBC. Compiling evidence has emerged implicating epigenetic changes as a common denominator linking the main risk factors (socioeconomic status, environmental exposure to endocrine disruptors, racial disparities, and obesity) with IBC development. DNA methylation changes and their impact on the diagnosis, prognosis, and treatment of IBC are also described. Recent studies are focusing on the use of histone deacetylase inhibitors as promising epigenetic drugs for treating IBC. All efforts must be undertaken to unravel the epigenetic marks that drive this disease and how this knowledge could impact strategies to reduce the risk of IBC development and progression.

摘要

有证据表明表观遗传改变与炎症性乳腺癌(IBC)的起源和进展有关。IBC 是一种罕见且进展迅速的疾病,被认为是最具侵袭性的乳腺癌(BC)类型。在临床表现上,IBC 的特征是弥漫性红斑、皮肤起皱、真皮淋巴管浸润和橘皮样外观。肿瘤作为栓塞物广泛分布于乳房内以及肿瘤内和肿瘤间异质性与预后不良有关。在这篇综述中,我们强调了一些研究,这些研究记录了表观遗传机制在重塑染色质和调节乳腺分化和 IBC 发展过程中基因表达方面的重要作用。越来越多的证据表明,表观遗传变化是将主要风险因素(社会经济地位、环境暴露于内分泌干扰物、种族差异和肥胖)与 IBC 发展联系起来的共同因素。还描述了 DNA 甲基化变化及其对 IBC 的诊断、预后和治疗的影响。最近的研究集中在使用组蛋白去乙酰化酶抑制剂作为治疗 IBC 的有前途的表观遗传药物。必须尽一切努力揭示驱动这种疾病的表观遗传标记,以及这些知识如何影响降低 IBC 发展和进展风险的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ce/7291154/9a3d15ef2cae/cells-09-01164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ce/7291154/2ae56f065622/cells-09-01164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ce/7291154/9a3d15ef2cae/cells-09-01164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ce/7291154/2ae56f065622/cells-09-01164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8ce/7291154/9a3d15ef2cae/cells-09-01164-g002.jpg

相似文献

1
Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.炎症性乳腺癌中的表观遗传学:生物学特征与治疗展望。
Cells. 2020 May 8;9(5):1164. doi: 10.3390/cells9051164.
2
Inflammatory breast cancer microenvironment repertoire based on DNA methylation data deconvolution reveals actionable targets to enhance the treatment efficacy.基于 DNA 甲基化数据解析的炎性乳腺癌微环境特征谱揭示了增强治疗效果的可行靶点。
J Transl Med. 2024 Aug 5;22(1):735. doi: 10.1186/s12967-024-05553-5.
3
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.在临床前模型中,间充质干细胞介导炎性乳腺癌的临床表型。
Breast Cancer Res. 2015 Mar 20;17(1):42. doi: 10.1186/s13058-015-0549-4.
4
Inflammatory Breast Cancer: a Separate Entity.炎性乳腺癌:一种独立的实体。
Curr Oncol Rep. 2019 Aug 15;21(10):86. doi: 10.1007/s11912-019-0842-y.
5
Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.炎性乳腺癌:关于这种独特且侵袭性乳腺癌的知识。
Surg Clin North Am. 2018 Aug;98(4):787-800. doi: 10.1016/j.suc.2018.03.009. Epub 2018 May 24.
6
A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.2007 - 2009年从医疗记录和监测、流行病学及最终结果数据库中识别炎性乳腺癌病例的标准比较。
Breast J. 2014 Mar-Apr;20(2):185-91. doi: 10.1111/tbj.12234. Epub 2013 Dec 26.
7
New Treatment Strategies for the Inflammatory Breast Cancer.炎性乳腺癌的新治疗策略。
Curr Treat Options Oncol. 2021 Apr 24;22(6):50. doi: 10.1007/s11864-021-00843-2.
8
Radiation for inflammatory breast cancer: Updates.炎性乳腺癌的放射治疗:最新进展。
Int Rev Cell Mol Biol. 2024;384:25-46. doi: 10.1016/bs.ircmb.2023.10.004. Epub 2023 Oct 19.
9
Reliability of medical records in diagnosing inflammatory breast cancer in Egypt.埃及医疗记录在诊断炎性乳腺癌方面的可靠性。
BMC Res Notes. 2017 Mar 16;10(1):126. doi: 10.1186/s13104-017-2433-z.
10
What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.放射科医生需要了解的炎性乳腺癌的诊断和治疗知识:多学科方法。
Radiographics. 2013 Nov-Dec;33(7):2003-17. doi: 10.1148/rg.337135503.

引用本文的文献

1
Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery.乳腺癌中的表观遗传修饰:从免疫逃逸机制到治疗靶点发现
Front Immunol. 2025 Apr 17;16:1584087. doi: 10.3389/fimmu.2025.1584087. eCollection 2025.
2
Unlocking the epigenetic code: new insights into triple-negative breast cancer.解开表观遗传密码:三阴性乳腺癌的新见解
Front Oncol. 2024 Dec 18;14:1499950. doi: 10.3389/fonc.2024.1499950. eCollection 2024.
3
Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study.

本文引用的文献

1
Role of BET Inhibitors in Triple Negative Breast Cancers.BET抑制剂在三阴性乳腺癌中的作用
Cancers (Basel). 2020 Mar 25;12(4):784. doi: 10.3390/cancers12040784.
2
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types.基于 DNA 甲基化的液体活检检测作为四大癌症类型的检测和预后生物标志物。
Cells. 2020 Mar 5;9(3):624. doi: 10.3390/cells9030624.
3
Small Molecules Targeting the Specific Domains of Histone-Mark Readers in Cancer Therapy.小分子靶向组蛋白标记读取器的特定结构域在癌症治疗中的应用。
炎性乳腺癌患者的病理完全缓解率和总生存率:一项国家癌症数据库研究。
Ann Surg Oncol. 2024 Nov;31(12):8057-8067. doi: 10.1245/s10434-024-16026-w. Epub 2024 Aug 19.
4
DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome.炎性乳腺癌的 DNA 甲基化图谱及其对预后和结局的影响。
Clin Epigenetics. 2024 Jul 6;16(1):89. doi: 10.1186/s13148-024-01695-x.
5
Comprehensive Characterization of Immune Cell Infiltration Characteristics and Drug Sensitivity Analysis in Inflammatory Breast Cancer Based on Bioinformatic Strategy.基于生物信息学策略的炎性乳腺癌免疫浸润特征的全面描述及药物敏感性分析。
Biochem Genet. 2024 Apr;62(2):1021-1039. doi: 10.1007/s10528-023-10460-3. Epub 2023 Jul 30.
6
Nanoparticle-Based Antioxidants in Stress Signaling and Programmed Cell Death in Breast Cancer Treatment.基于纳米颗粒的抗氧化剂在乳腺癌治疗中的应激信号和程序性细胞死亡中的作用。
Molecules. 2023 Jul 10;28(14):5305. doi: 10.3390/molecules28145305.
7
Predictive value of controlling nutritional status score in postoperative recurrence and metastasis of breast cancer patients with HER2-low expression.控制营养状况评分对HER2低表达乳腺癌患者术后复发和转移的预测价值
Front Oncol. 2023 Jul 10;13:1116631. doi: 10.3389/fonc.2023.1116631. eCollection 2023.
8
Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis.Metadherin 调节炎症性乳腺癌的侵袭和转移。
Int J Mol Sci. 2023 Feb 28;24(5):4694. doi: 10.3390/ijms24054694.
9
HER2/positive and HER2/low in inflammatory breast cancer recurrence.炎性乳腺癌中 HER2 阳性和 HER2 低表达与复发的关系。
J Med Life. 2022 Dec;15(12):1573-1578. doi: 10.25122/jml-2022-0213.
10
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies.抗雌激素治疗耐药性的分子机制及新型靶向治疗
Cancers (Basel). 2022 Oct 24;14(21):5206. doi: 10.3390/cancers14215206.
Molecules. 2020 Jan 29;25(3):578. doi: 10.3390/molecules25030578.
4
The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.长链非编码 RNA DANCR 通过 EZH2 依赖性抑制 SOCS3 转录调节乳腺癌细胞的炎症表型并促进乳腺癌进展。
Mol Oncol. 2020 Feb;14(2):309-328. doi: 10.1002/1878-0261.12622. Epub 2020 Jan 10.
5
Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation.膳食脂肪与肥胖作为乳腺癌风险的调节因素:聚焦于DNA甲基化
Br J Pharmacol. 2020 Mar;177(6):1331-1350. doi: 10.1111/bph.14891. Epub 2020 Jan 26.
6
Single-Cell Chromatin Analysis of Mammary Gland Development Reveals Cell-State Transcriptional Regulators and Lineage Relationships.单细胞染色质分析揭示了乳腺发育中的细胞状态转录调控因子和谱系关系。
Cell Rep. 2019 Oct 8;29(2):495-510.e6. doi: 10.1016/j.celrep.2019.08.089.
7
Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise.将表观遗传学药物与其他疗法联合用于实体瘤——过去的经验教训和未来的前景。
Nat Rev Clin Oncol. 2020 Feb;17(2):91-107. doi: 10.1038/s41571-019-0267-4. Epub 2019 Sep 30.
8
The emerging role of epigenetic therapeutics in immuno-oncology.表观遗传学治疗在肿瘤免疫治疗中的新兴作用。
Nat Rev Clin Oncol. 2020 Feb;17(2):75-90. doi: 10.1038/s41571-019-0266-5. Epub 2019 Sep 23.
9
Inflammatory Breast Cancer: a Separate Entity.炎性乳腺癌:一种独立的实体。
Curr Oncol Rep. 2019 Aug 15;21(10):86. doi: 10.1007/s11912-019-0842-y.
10
Epidrugs: targeting epigenetic marks in cancer treatment.表观遗传学药物:癌症治疗中的靶向表观遗传标记。
Epigenetics. 2019 Dec;14(12):1164-1176. doi: 10.1080/15592294.2019.1640546. Epub 2019 Jul 13.